LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 32 of 497
Next
>>
>
776 to 800 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Buparlisib	0.37	uM	LJP5	2	H04	72	hr	1657	3613	5505	0.6562	0.5081
BT-20	Buparlisib	0.37	uM	LJP5	3	H04	72	hr	1657	3839	5505	0.6973	0.5669
BT-20	BX-912	0.37	uM	LJP5	1	L22	72	hr	1657	5729	5505	1.0406	1.0580
BT-20	BX-912	0.37	uM	LJP5	2	L22	72	hr	1657	4970	5505	0.9027	0.8608
BT-20	BX-912	0.37	uM	LJP5	3	L22	72	hr	1657	5670	5505	1.0298	1.0427
BT-20	Canertinib	0.37	uM	LJP6	1	H10	72	hr	1657	4496	5505	0.8166	0.7376
BT-20	Canertinib	0.37	uM	LJP6	2	H10	72	hr	1657	4613	5505	0.8379	0.7680
BT-20	Canertinib	0.37	uM	LJP6	3	H10	72	hr	1657	4597	5505	0.8350	0.7639
BT-20	Celastrol	0.37	uM	LJP6	1	G10	72	hr	1657	4489	5505	0.8153	0.7358
BT-20	Celastrol	0.37	uM	LJP6	2	G10	72	hr	1657	4557	5505	0.8277	0.7535
BT-20	Celastrol	0.37	uM	LJP6	3	G10	72	hr	1657	4778	5505	0.8678	0.8109
BT-20	CGP60474	0.37	uM	LJP5	1	F04	72	hr	1657	1481	5505	0.2690	-0.0459
BT-20	CGP60474	0.37	uM	LJP5	2	F04	72	hr	1657	1619	5505	0.2941	-0.0101
BT-20	CGP60474	0.37	uM	LJP5	3	F04	72	hr	1657	1524	5505	0.2768	-0.0348
BT-20	CGP60474	0.37	uM	LJP6	1	G04	72	hr	1657	1047	5505	0.1902	-0.1587
BT-20	CGP60474	0.37	uM	LJP6	2	G04	72	hr	1657	1119	5505	0.2033	-0.1400
BT-20	CGP60474	0.37	uM	LJP6	3	G04	72	hr	1657	932	5505	0.1693	-0.1886
BT-20	CHIR-99021	0.37	uM	LJP6	1	P16	72	hr	1657	5438	5505	0.9877	0.9824
BT-20	CHIR-99021	0.37	uM	LJP6	2	P16	72	hr	1657	5574	5505	1.0124	1.0178
BT-20	CHIR-99021	0.37	uM	LJP6	3	P16	72	hr	1657	5522	5505	1.0030	1.0042
BT-20	CP724714	0.37	uM	LJP5	1	A10	72	hr	1657	5057	5505	0.9185	0.8834
BT-20	CP724714	0.37	uM	LJP5	2	A10	72	hr	1657	4815	5505	0.8746	0.8205
BT-20	CP724714	0.37	uM	LJP5	3	A10	72	hr	1657	4799	5505	0.8717	0.8164
BT-20	CP466722	0.37	uM	LJP5	1	I10	72	hr	1657	5858	5505	1.0640	1.0916
BT-20	CP466722	0.37	uM	LJP5	2	I10	72	hr	1657	5900	5505	1.0716	1.1025

|<
<<
Previous
Page 32 of 497
Next
>>
>
776 to 800 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)